217 related articles for article (PubMed ID: 16785827)
21. Anti-inflammatory agents and renal function.
Brater DC
Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):33-42. PubMed ID: 12528072
[TBL] [Abstract][Full Text] [Related]
22. Cardio-renal safety of non-steroidal anti-inflammatory drugs.
Radi ZA; Khan KN
J Toxicol Sci; 2019; 44(6):373-391. PubMed ID: 31168026
[TBL] [Abstract][Full Text] [Related]
23. [Case report: reversible acute renal failure following therapy with both ketorolac (non-selective non-steroidal anti-inflammatory drug NSAID) and celecoxib (COX-2 selective) in the same patient].
Galli G; Panzetta G
G Ital Nefrol; 2002; 19(2):199-203. PubMed ID: 12195419
[TBL] [Abstract][Full Text] [Related]
24. Interspecies differences in renal localization of cyclooxygenase isoforms: implications in nonsteroidal antiinflammatory drug-related nephrotoxicity.
Khan KN; Venturini CM; Bunch RT; Brassard JA; Koki AT; Morris DL; Trump BF; Maziasz TJ; Alden CL
Toxicol Pathol; 1998; 26(5):612-20. PubMed ID: 9789947
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological profile of FK881(ASP6537), a novel potent and selective cyclooxygenase-1 inhibitor.
Imanishi J; Morita Y; Yoshimi E; Kuroda K; Masunaga T; Yamagami K; Kuno M; Hamachi E; Aoki S; Takahashi F; Nakamura K; Miyata S; Ohkubo Y; Mutoh S
Biochem Pharmacol; 2011 Oct; 82(7):746-54. PubMed ID: 21745460
[TBL] [Abstract][Full Text] [Related]
26. The cardiovascular pharmacology of COX-2 inhibition.
Fries S; Grosser T
Hematology Am Soc Hematol Educ Program; 2005; ():445-51. PubMed ID: 16304418
[TBL] [Abstract][Full Text] [Related]
27. Do non-steroidal anti-inflammatory drugs and COX-2 selective inhibitors have different renal effects?
Giovanni G; Giovanni P
J Nephrol; 2002; 15(5):480-8. PubMed ID: 12455713
[TBL] [Abstract][Full Text] [Related]
28. Renal functional responses to ischaemia-reperfusion injury in normotensive and hypertensive rats following non-selective and selective cyclo-oxygenase inhibition with nitric oxide donation.
Knight S; Johns EJ
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):11-6. PubMed ID: 18047621
[TBL] [Abstract][Full Text] [Related]
29. [Nonsteroidal antiinflammatory drugs and the kidney].
Zadrazil J
Vnitr Lek; 2006; 52(7-8):686-90. PubMed ID: 16967609
[TBL] [Abstract][Full Text] [Related]
30. Nonsteroidal anti-inflammatory drugs and heart failure.
Bleumink GS; Feenstra J; Sturkenboom MC; Stricker BH
Drugs; 2003; 63(6):525-34. PubMed ID: 12656651
[TBL] [Abstract][Full Text] [Related]
31. The pharmacology of selective inhibition of COX-2.
Grosser T
Thromb Haemost; 2006 Oct; 96(4):393-400. PubMed ID: 17003913
[TBL] [Abstract][Full Text] [Related]
32. [Coxibs: cyclooxygenase-2 inhibitors].
Turnheim K
Wien Klin Wochenschr; 2001 Aug; 113(15-16):558-65. PubMed ID: 11571832
[TBL] [Abstract][Full Text] [Related]
33. Dual acting anti-inflammatory drugs: a reappraisal.
Bertolini A; Ottani A; Sandrini M
Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
[TBL] [Abstract][Full Text] [Related]
34. Preclinical pharmacology of robenacoxib: a novel selective inhibitor of cyclooxygenase-2.
King JN; Dawson J; Esser RE; Fujimoto R; Kimble EF; Maniara W; Marshall PJ; O'Byrne L; Quadros E; Toutain PL; Lees P
J Vet Pharmacol Ther; 2009 Feb; 32(1):1-17. PubMed ID: 19161451
[TBL] [Abstract][Full Text] [Related]
35. The "aspirin" of the new millennium: cyclooxygenase-2 inhibitors.
Buttar NS; Wang KK
Mayo Clin Proc; 2000 Oct; 75(10):1027-38. PubMed ID: 11040851
[TBL] [Abstract][Full Text] [Related]
36. Cyclo-oxygenase-2 inhibitors and the kidney: a case for caution.
Noroian G; Clive D
Drug Saf; 2002; 25(3):165-72. PubMed ID: 11945113
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays.
Riendeau D; Charleson S; Cromlish W; Mancini JA; Wong E; Guay J
Can J Physiol Pharmacol; 1997 Sep; 75(9):1088-95. PubMed ID: 9365818
[TBL] [Abstract][Full Text] [Related]
38. Cyclo-oxygenase-2 inhibitors: when should they be used in the elderly?
Savage R
Drugs Aging; 2005; 22(3):185-200. PubMed ID: 15813652
[TBL] [Abstract][Full Text] [Related]
39. The Coxib case: Are EP receptors really guilty?
Santilli F; Boccatonda A; Davì G; Cipollone F
Atherosclerosis; 2016 Jun; 249():164-73. PubMed ID: 27105159
[TBL] [Abstract][Full Text] [Related]
40. Nonsteroidal Anti-Inflammatory Drugs and the Kidney.
Hörl WH
Pharmaceuticals (Basel); 2010 Jul; 3(7):2291-2321. PubMed ID: 27713354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
